Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FXAGT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,122
Award facts
- Contract value 100% obligated
- $14,122.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,122.12 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Cimzia 2x200 mg/ml syringe kits. The contract, designated as non-competitive with firm fixed pricing, is scheduled for completion by October 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as the primary vehicle for comprehensive pharmaceutical and medical supply support to military and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a prominent position as a critical vendor within the Defense Logistics Agency's medical supply chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a diverse range of pharmaceutical products across multiple therapeutic domains to support military healthcare operations globally. This particular delivery order for Cimzia, a specialty pharmaceutical used in the treatment of inflammatory conditions, exemplifies the routine execution of smaller-value transactions within the company's broader strategic partnership with DLA to maintain consistent pharmaceutical availability for the Defense Health Agency and other federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FXAGT?
SPE2DB25FXAGT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FXAGT worth?
The government has obligated $14,122 on SPE2DB25FXAGT.
Is contract SPE2DB25FXAGT an order under another contract?
Yes. SPE2DB25FXAGT is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXAGT competed?
The extent of competition for SPE2DB25FXAGT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award